Amgen Research (Munich) GmbH

Amgen Research (Munich) GmbH is a company in Munchen, Germany that has taken part in 3 EU-funded projects since 2019.

EU funding receivedNot recorded
EU projects3
As coordinator0
Running now2
First EU project2019
Latest project2024
CountryGermany
EU registration (PIC)903792360
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Amgen Research (Munich) GmbH's own share of each project, not the project's full budget.

  • Horizon Europe€0 · 2 projects
  • Horizon 2020€0 · 1 project

Projects

3 EU-funded projects, newest first. Each links to the official record.

  • SEARCHAssociated partner

    Synthetic hEalthcare dAta goveRnanCe Hub

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • VICT3RPartner

    Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • MELLODDYPartner

    MachinE Learning Ledger Orchestration for Drug DiscoverY

    Horizon 2020 · 2019–2022 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • artificial intelligence
  • databases
  • drug discovery
  • governance
  • machine learning
  • software
  • toxicology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime